Determination of Serum Antibody toBordetella pertussisAdenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults with Pertussis
Open Access
- 15 February 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (4) , 502-507
- https://doi.org/10.1086/381204
Abstract
Presence of antibody to adenylate cyclase toxin (ACT) has been noted following Bordetella pertussis infection. Because ACT is not presently in any acKeywords
This publication has 19 references indexed in Scilit:
- Serologic Response and Antibody‐Titer Decay in Adults with PertussisClinical Infectious Diseases, 2004
- Antibody Responses to Bordetella pertussis Antigens and Clinical Correlations in Elderly Community ResidentsClinical Infectious Diseases, 2000
- Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccineThe Lancet, 1997
- Bordetella pertussis adenylate cyclase toxin: proCyaA and CyaC proteins synthesised separately in Escherichia coli produce active toxin in vitroGene, 1996
- Household Contact Study of Bordetella pertussis InfectionsClinical Infectious Diseases, 1995
- Antibodies toBordetella pertussisadenylate cyclase toxin in neonatal and maternal seraFEMS Immunology & Medical Microbiology, 1993
- Hemolytic activity of adenylate cyclase toxin fromBordetella pertussisFEBS Letters, 1991
- Human Serologic Response to Envelope-Associated Proteins and Adenylate Cyclase Toxin of Bordetella pertussisThe Journal of Infectious Diseases, 1991
- Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccinationJournal of Medical Microbiology, 1990
- Identification of a common domain in calmodulin-activated eukaryotic and bacterial adenylate cyclasesBiochemistry, 1989